American Cancer Society releases detailed prostate cancer screening recommendations
सिर्फ तथ्य

American Cancer Society releases detailed prostate cancer screening recommendations

सारांश

The American Cancer Society updated its prostate cancer screening guidelines, advising biennial PSA testing for average-risk men aged 50-69 and earlier testing for higher-risk groups.

The American Cancer Society on Thursday issued new prostate cancer screening guidelines that call for men at average risk to begin prostate-specific antigen (PSA) blood testing every two years between ages 50 and 69. Men identified as higher risk, including Black men and those with a strong family history, are advised to start testing at age 45.

For men aged 70 to 74, the guidelines recommend a discussion with a physician about the potential benefits and drawbacks of continued screening, while men 75 and older or those with a life expectancy under ten years should discontinue PSA testing. The society also suggests that men with PSA levels of 3.0 ng/mL or higher be screened annually, whereas those with levels of 2.5 ng/mL or lower continue biennial testing.

"We thought it was really important to update our prostate cancer guidelines, because now there is true evidence that prostate cancer screening with the PSA test, a blood test, can actually decrease one's chance of dying from prostate cancer," said ACS chief scientific officer Dr. William Dahut.

The update notes that Black men face a higher incidence of prostate cancer and are more than twice as likely to die from the disease, according to CDC data. In 2023, the United States recorded over 266,000 new prostate cancer cases, and more than 34,000 deaths were reported in 2024.

The new ACS recommendations differ from those of other medical bodies. The CDC and the U.S. Preventive Services Task Force leave PSA testing decisions to individual patients and doctors, recommending against screening men over 70. The American Academy of Family Physicians does not endorse PSA screening, while the American College of Physicians and the American Urological Association advise screening for men 50-69 (or 55-69) with a life expectancy of at least ten years, with earlier testing for high-risk individuals. Adoption of the ACS guidelines by the broader medical community may take several years, though many clinicians already follow its recommendations.

पढ़ते रहें — निःशुल्क

समाचार फ़ॉलो करने के लिए मुफ़्त खाता बनाएँ। कार्ड की आवश्यकता नहीं।